Medtronic (NYSE:MDT) has a definitive deal to acquire privately held Titan Spine, makers of titanium interbody implant and surface technology.

Financial terms weren’t disclosed, but Medtronic says it’s expected to be immaterial to fiscal 2020 EPS and will meet long-term metrics for acquisitions.

Wisconsin-based Titan Spine markets a full line of Endoskeleton interbody devices featuring a proprietary textured surface to the U.S., Europe and Australia.

Both boards have unanimously approved of the deal.


READ  VW Golf knocks the BMW 3 Series off its perch to become the most searched for car of the year


Please enter your comment!
Please enter your name here